logo

IBO

Impact BioMedicalยทAMEX
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

IBO Profile

Impact Biomedical Inc.

A pharmaceutical research and biomedical intellectual property company

Pharmaceutical
10/16/2018
09/16/2024
American Stock Exchange
2
12-31
Common stock
1400 Broadfield Blvd., Suite 130, Houston, TX 77084
--
Impact BioMedical Inc., a Nevada corporation, was founded on October 16, 2018. The company is a subsidiary of DSS, Inc. Through licensing, co-development, joint ventures and other relationships, the company works with external partners to discover, identify and patent unique science and technology that can be developed into new products in the field of human healthcare and wellness.